Ondansetron Tablet, Orally Disintegrating
Product Images NDC 70518-3512

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 70518-3512). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Ondansetron 4 mg orally disintegrating tablets, packaged in a quantity of 30 tablets. Label indicates the product is by RemedyRepack Inc. The label includes standard regulatory information such as RX only status, NDC number 70518-3512-00, manufacturer Glenmark details, storage conditions, and a QR code.*

FDA Label Image

Structure-base (Structure Base)

Chemical structure of ondansetron, showing its molecular framework including fused rings and functional groups consistent with the active ingredient of Ondansetron orally disintegrating tablets.*

FDA Label Image

Structure-hcl (Structure HCl)

Chemical structure of Ondansetron hydrochloride dihydrate is shown, depicting its molecular arrangement including benzene rings, nitrogen atoms, a ketone group, methyl groups, and dihydrate with hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.